Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable caffeine oxidase activity; heme binding activity; and monooxygenase activity. Acts upstream of or within hematopoietic progenitor cell differentiation. Predicted to be located in plasma membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in several diseases, including end stage renal disease; glucose metabolism disease (multiple); head and neck squamous cell carcinoma; hypertension (multiple); and warfarin resistance. Orthologous to human CYP2C8 (cytochrome P450 family 2 subfamily C member 8) and CYP2C9 (cytochrome P450 family 2 subfamily C member 9).